Abstract: Caveolae-and clathrin-mediated endocytosis are major internalization pathways used by several pathogens; however, their distinctive roles in dengue virus (DV) entry have not been addressed. In this study, we compared the involvement of caveolae-and clathrin-mediated endocytosis in the infectious entry of DV serotype 2 (DV2) into human endothelial-like ECV304 cells. Confocal microscopy study on DV2-infected cells showed that viral antigens were co-localized with clathrin heavy chains, epidermal growth factor pathway substrate clone 15 (Eps15), and adaptin-a, but not with caveolin-1. Treatment with chlorpromazine, which inhibits clathrin-dependent endocytosis, led to reduced virus entry into cells, whereas treatment with nystatin, a caveolae inhibitory agent, did not. Furthermore, gene silencing of Eps15 resulted in an average of 75% reduced infection of ECV304 cells by DV2. Our results demonstrated that DV2 enters ECV304 cells by clathrin-dependent endocytosis, not by caveolae-dependent endocytosis.
Introduction
Dengue virus (DV) is an enveloped, single-stranded RNA virus belonging to the family Flaviviridae. DV infection causes a wide range of symptoms from an unapparent or mild disease (dengue fever, DF) to severe, life-threatening complications (dengue hemorrhagic fever / dengue shock syndrome, DHF/DSS). The clinical symptoms of DHF/DSS include plasma leakage, hemorrhagic abnormalities, and thrombocytopenia. However, the pathogenic mechanism of DHF/DSS is not clear.
The entry event is often a major determinant of virus host and tissue tropism. Establishment of infection requires entry of DV into host cells, followed by retrograde transport of the viral genome to an appropriate site for replication. Generally, the viral genome can enter the cytoplasm directly at the cell surface by penetrating the plasma membrane or after endocytosis by penetrating membranes of intracellular organelles (Pelkmans and Helenius 2003) . Thus, the analysis of early virus-cell interactions may provide insights not only into the infectious cycle, but also into potential antiviral strategies.
Many virus families utilize endocytosis to infect host cells, mediating virus internalization and trafficking to the site of replication. The endocytic pathways utilized include macropinocytosis, caveolae-dependent endocytosis, clathrindependent endocytosis, and other pathways that are presently poorly characterized. Macropinocytosis is a major route of entry into antigen-presenting cells, such as dendritic cells, and is generally considered to be a nonspecific mechanism for internalization. Caveolae are plasma membrane invaginations that transport the virus, such as simian virus 40, to the endoplasmic reticulum (ER) instead of to the endosomallysosomal compartment (Pelkmans et al. 2001) . Clathrincoated vesicles are known to be involved in receptor-mediated endocytosis from plasma membranes to early endosomes, and transport from the trans-Golgi network to endosomes (Rappoport et al. 2004 ). Both enveloped and nonenveloped viruses have been shown to use clathrin-dependent endocytosis for infection, such as hepatitis C virus, influenza virus, and feline calicivirus (Blanchard et al. 2006; Rust et al. 2004; Stuart and Brown 2006) . West Nile virus was the first flavivirus shown to enter via clathrin-dependent endocytosis (Chu and Ng 2004 ). An earlier study reported that DV entry occurred by direct fusion with the plasma membrane in both mammalian and mosquito cells (Se-Thoe et al. 2000) . Later studies showed that DV enters a host cell when the viral envelope glycoprotein binds to a receptor and responds by conformational rearrangement to the reduced pH of an endosome (Kuhn et al. 2002; Modis et al. 2003 Modis et al. , 2004 . Recently, it has been reported that entry of DV into HeLa cells is also associated with clathrin-coated vesicles (Krishnan et al. 2007 ). However, the endocytic mechanisms utilized by DV for entering endothelial cells are still poorly understood.
In the present study, we compared the involvement of caveolae-and clathrin-mediated endocytosis in the infectious entry of DV serotype 2 (DV2) into human endotheliallike ECV304 cells. Co-localization studies with endocytosisassociated molecules (clathrin, Eps15, adaptin-a, tranferrin, and caveolin) implicated clathrin-dependent, not caveolaedependent, endocytosis in the infection of DV2. Treatment with chlorpromazine, which inhibits clathrin-dependent endocytosis, led to reduced virus entry into cells, whereas treatment with nystatin, a caveolae inhibitory agent, did not. Moreover, RNA silencing of Eps15, an important component of clathrin-dependent endocytosis, strongly inhibited the DV2 infection. Our results demonstrated that DV2 enters and infects ECV304 cells through clathrin-dependent endocytosis, not through caveolae-dependent endocytosis.
Materials and methods

Cell cultures and virus preparation
Cells of the monkey kidney line Vero (America Type Culture Collection, Manassas, Virginia) were maintained in Dulbecco's modified Eagle's medium (DMEM) (HyClone, Logan, Utah) containing 5% fetal bovine serum (FBS). ECV304 cells, a cell line derived from human umbilical vein endothelial cells (European Collection of Cell Cultures), were cultured in DMEM supplemented with 10% FBS.
ECV304 cells that had been transfected with an Eps15-targeting small interfering (siRNA) vector, pUHeps15, and a control plasmid, pUHcont, were named ECV304 and ECV304 N , respectively, and have been described previously (Jian et al. 2006) . These cells were grown in DMEM containing 10% FBS and 1 mg/mL of the neomycin analogue G418 sulfate (Calbiochem, San Diego, California).
DEN-2 (strain Tr1751) virus, which was isolated from a patient with DF and kindly provided by A. Oya (National Institute of Infectious Diseases, Japan), was propagated in forest day mosquito (Aedes albopictus (Skuse, 1895)) (C6/36) cells and stored at -70 8C until use . The viral titer was determined by the plaque assay, using a Vero cell monolayer culture under 1% methylcellulose overlay medium.
Antibodies and chemicals
Anti-adaptin-a (610501) and anti-clathrin heavy chains (CHC, 610499) mouse monoclonal antibodies (mAb) were purchased from BD Biosciences Pharmingen. and anti-caveolin-1 (c3237) rabbit polyclonal antibodies (pAb) were purchased from Santa Cruz Biotechnology. TRITC-conjugated goat anti-rabbit-IgG and Cy3-conjugated goat anti-mouse-IgG, fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG1, FITC-conjugated goat anti-rabbit IgG, chlorpromazine, nystatin and glycerol mount were all obtained from Sigma-Aldrich. Texas Redconjugated transferrin (TR-transferrin) was purchased from Molecular Probes (Eugene, Oregon).
Inhibition of DV2 entry with drugs
Two drugs, chlorpromazine and nystatin, were stored at -20 8C as 1 mg/mL stock solutions in dimethyl sulfoxide (DMSO). First, the cytotoxicity of the drugs to ECV304 cells was determined, using the 3-(4,5-dimethylthiazol-2-yl)-diphenyl tetrazolium bromide (MTT; Sigma-Aldrich) method (Mosmann 1983; Denizot and Lang 1986) . From this, 5 mg/mL of chlorpromazine and 15 mg/mL of nystatin were used as the working concentrations, and DMSO was added at the same concentration to the control cells (mock treatment).
Confluent monolayers of ECV304 cells grown in 6-well plates were incubated with chlorpromazine (5 mg/mL) or nystatin (15 mg/mL) for 1 h at 37 8C. Then, the culture medium was removed and the cells were inoculated in the continued presence of chlorpromazine or nystatin with DV2 at a multiplicity of infection (MOI) of 1 for 2 h at 37 8C. Infected cells were treated with acid glycine buffer (pH 3.0) for 1 min to inactivate extracellular virus (Hung et al. 1999) . After extensive washing, for detection of the intracellular DV2 titer at 0 h postinfection (p.i.), the cells were taken out immediately and stored at -70 8C. For detection of intracellular DV2 titers at 4, 8, and 24 h p.i., the cells were incubated continuously with medium containing chlorpromazine or nystatin at 37 8C until viral titer detection. All of the cell samples were freeze-thawed 3 times for detection of the viral titer by plaque assay. The efficiency of virus entry was evaluated by analyzing changes in intracellular DV2 titers after drug treatment. Five independent experiments were performed for each time point.
DV2 entry assay in ECV304 N and ECV304 Eps15(-) cells
First, endocytic activity in ECV304 N and ECV304 Eps15(-) cells was analyzed by examining the uptake of human transferrin. Briefly, cells grown in 6-well plates were incubated with 2 mL of DMEM, containing 20 mg of TR-transferrin for 2 min. Then, the cells were washed with acid glycine buffer (pH 3.0), to remove transferrin from the plasma membrane, and were analyzed using a laser scanning confocal microscope (Leica TCS SP2).
Infectious entry assays for DV2 were performed using ECV304 and ECV304 N cells grown in 6-well tissue culture plates. The confluent monolayer of cells was first incubated in DMEM, supplemented with 2% FBS, for 30 min at 37 8C, then infected with DV2 (MOI = 1) for 2 h at 37 8C. Excess or unbound virus was inactivated with acid glycine buffer (pH 3.0) and removed by extensive washing. Then, the cells were taken out immediately for detection of the titer of intracellular DV2 at 0 h p.i. For detection of intracellular DV2 titers at 4, 8, and 24 h p.i., the cells were maintained in DMEM, supplemented with 2% FBS, at 37 8C until viral titer detection. The efficiency of virus entry was analyzed by detecting the titers of intracellular DV2, according to the method above. Five independent experiments were performed for each time point.
Indirect immunofluorescence staining Double immunofluorescence staining was used for analyzing co-localization of the DV2 antigen with clathrin-dependent endocytic pathway proteins (CHC, Eps15, or adaptin-a) or a caveolae endocytic pathway protein (caveolin-1) in infected ECV304 cells. Briefly, ECV304 cells were grown on glass cover slips for 18-24 h to 80% confluency and were infected with DV2 (MOI = 5) or heat-inactivated DV2 (56 8C, 30 min, mock-infected) for 1 h at 37 8C. At 48 h after infection, the cover slips were washed and fixed with cold methanol. Non-specific binding sites were blocked with 1% bovine serum albumin in phosphate-buffered saline (PBS) and the cells were incubated with rabbit or mouse anti-DV2 primary antibody at 4 8C overnight. After washing with PBS, the cells were incubated with FITC-conjugated anti-rabbit IgG or FITC-conjugated antimouse IgG1 for 1 h at 37 8C, to detect DV2 antigens, followed by a 1-h incubation at 37 8C with anti-Eps15 or anti-caveolin-1 rabbit pAbs or anti-CHC or anti-adaptin-a mouse mAbs. After washing with PBS, the cells were incubated with TRITC-conjugated anti-rabbit IgG or Cy3-conjugated anti-mouse IgG1 for 1 h at 37 8C.
For analysis of internalization and co-localizaion of transferrin with DV2 in ECV304 cells, the cells were infected with DV2 (MOI = 1) and were maintained in DMEM with 2% FBS. At 48 h after infection, the medium was removed and the cells were incubated with 2 mL of DMEM containing 20 mg of TR-transferrin for 2 min. Then, the cells were washed with acid glycine buffer (pH 3.0) to remove transferrin from the plasma membrane and then fixed. To detect DV2 antigens, the cells were incubated with mouse anti-DV2 pAb, followed by the FITC-conjugated anti-mouse IgG1. All the cover slips were mounted with glycerol mount, and analyzed using a confocal laser microscope (Leica TCS SP2).
Statistical analysis
Data were analyzed using the SPSS software (version 8.0 for Windows). Differences were deemed statistically significant when p < 0.05.
Results
DV2 showed high co-localization with the clathrindependent endocytic pathway
The clathrin-dependent and caveolae-dependent endocytic pathways are 2 major receptor-mediated internalization pathways. To determine their roles in DV infection, we performed a confocal microscopy study on ECV304 cells that were infected and then exposed to transferrin (Fig. 1) . At 48 h p.i., the DV2 signal was present primarily in the perinuclear region of the cell, closely co-localized with CHC and Eps15 and partially co-localized with adaptin-a (Figs. 1A-C) . Meanwhile, the fluorescence of CHC and Eps15 in infected cells became brighter than that observed in uninfected cells. However, co-localization of DV antigens with caveolin-1 was rarely observed (Fig. 1D) . This suggested that the endocytosis of DV2 may be associated with the clathrin-dependent pathway, not with the caveolaedependent pathway. It is interesting that DV2 antigens and transferrin receptor were highly concentrated within the same pericentrosomal region (Fig. 1E) , indicating that DV2 and recycling endosomes share an overlapping distribution in these cells. Thus, this evidence suggests that DV2 infection in ECV304 cells is likely to occur through the clathrin-dependent endocytic pathway.
Entry of DV2 into ECV304 cells was inhibited by treatment with chlorpromazine
To provide additional support for our confocal microscopy study, ECV304 cells were treated with 2 compounds that are known to selectively inhibit each of the specific pathways. The MTT assay showed that the viability of the cells was not affected by treatment with 5 mg/mL of chlorpromazine or 15 mg/mL of nystatin (data not shown). ECV304 cells were pretreated with chlorpromazine or nystatin for 1 h and then infected with DV2 in the presence of the drug for another hour. The yield of intracellular virus particles at different time points p.i. was determined by standard plaque assay. The titers were expressed as plaqueforming units (PFU) per milliliter ( Fig. 2A) . Results are also presented as the percentage of virus titer compared with the mock-treated controls (Fig. 2B) . Results showed that treatment with chlorpromazine reduced the intracellular DV2 titers to 59% right after infection (at 0 h p.i.), indicating entry efficiency of DV2 was impaired by the inhibition of receptor-mediated endocytosis. At the later time points, intracellular virus titer of chlorpromazine-treated cells were reduced up to 34% at 8 h p.i. and to 56% at 24 h p.i., compared with that of mock-treated cells. However, treatment with nystatin only resulted in slight reductions of DV2 infection. The results supported the hypothesis that the clathrin-mediated endocytosis is likely to be a major pathway for the infectious entry of DV2 into ECV304 cells.
Gene silencing of Eps15 in ECV304 cells prevented DV2 infection
To affirm the involvement of the clathrin-mediated endocytosis pathway in the entry of DV2, gene silencing of Eps15 was carried out. In our previous work, Eps15-targeting siRNA vector and control vector pUNH were stably transfected into ECV304 cells (Jian et al. 2006 ). The internalization of TR-transferrin was impaired in ECV304 cells, but not in ECV304 N cells. In the present study, cells were infected with DV2 for 1 h at 37 8C and the yield of intracellular virus particles at different time points p.i. was determined by plaque assay. The titers were expressed as PFU/mL (Fig. 3A) . Results showed that silencing of Eps15 inhibited DV2 infection of ECV304 cells significantly. Data are also presented as the percentages of virus titer compared with the mock-treated controls (Fig. 3B) . After infection (at 0 h p.i.), the intracellular virus titer of EC-V304 Eps15(-) cells was reduced by 73%, indicating that entry efficiency of DV2 was inhibited by silencing of Eps15, a clathrin-coat-associated protein that binds the adaptin-a subunit. It was worthy of note that the inhibition level of intracellular virus titer in ECV304 reached 77% at 24 h p.i. These results demonstrated that DV2 was taken up by the cells through the clathrin-dependent endocytic pathway, and suggested Eps15 is likely to be involved in the replication of DV2 in ECV304 cells.
Discussion
As obligate intracellular parasites, all viruses must have ways of entering target cells to initiate replication and infection. Many viruses are known to hijack endocytic pathways. Several endocytic pathways have recently been identified, including clathrin-mediated endocytosis, caveolae, macropinocytosis, and novel non-clathrin, non-caveolae pathways (Sieczkarski and Whittaker 2002b) . Little specific information and no cellular markers for non-clathrin, noncaveolae-dependent endocytosis are available, and the role of macropinocytosis in DV entry is currently being carried out in another study. Thus, in this study, we focused on whether the uptake of DV2 by ECV304 cells occurred via the clathrin-or caveolae-dependent pathway. First, the confocal study demonstrated that high fluorescence intensity for CHC and Eps15, not cavealin-1, showed the close colocalization with DV2 antigens in the perinuclear regions of the infected cells, indicating that DV2 infection may induce upregulated expression of CHC and Eps15. Additionally, DV2 showed partial co-localization with adaptin-a and close co-localization with TR-transferrin, a cellular marker of clathrin-mediated endocytosis. These observations suggest that DV2 is likely to enter ECV304 cells through the clathrin-mediated endocytic pathway, not through the caveolae-dependent endocytic pathway.
Next, to investigate the roles of clathrin-or caveolaedependent pathways in DV2 entry, 2 drugs that selectively inhibit each pathway were used. Chlorpromazine is a cationic amphiphilic drug and has been shown to prevent recycling of clathrin by accumulating clathrin and adaptin-a in endosomal compartments, thus inhibiting clathrin-dependent endocytosis (Wang et al. 1993) . Nystatin is a sterol-binding drug that sequesters cholesterol, a prominent component of lipid rafts involved in caveolae formation (Anderson et al. 1996) . Chlorpromazine has been extensively used to analyze the involvement of clathrin-dependent endocytosis of ligands and viruses. In this study, treatment of ECV304 cells with chlorpromazine perceptibly reduced intracellular viral titers to 59% right after internalization, whereas nystatin treatment barely had any effect. This result further supports that clathrin mediated-endocytosis is likely to be involved in the entry of DV2 into ECV304 cells. In a previous study (Krishnan et al. 2007 ), pretreatment of chlorpromazine reduced the virus positive cells to 20% at 16 h p.i. Considering the difference of sensitivity between the assay methods (measuring virus titer and counting virus positive cells), these 2 studies were consistent. Interestingly, our results showed that intracellular viral titers were also decreased at later time points (4, 8, and 24 h p.i.) , indicating that the drug may be influencing a stage in viral replication other than entry.
Eps15 is an important accessory factor that regulates clathrin-mediated endocytosis. Gene silencing of Eps15 by RNAi strongly perturbed clathrin-dependent endocytosis (Jian et al. 2006) . We used this approach to further examine the role of clathrin-mediated endocytosis in the entry of DV2 into ECV304 cells. As expected, the titers of intracellular DV2 in ECV304 Eps15(-) cells were perceptibly reduced after internalization, indicating that clathrin-mediated-endocytosis may be a major pathway for DV2 infectious entry into ECV304 cells. Interestingly, intracellular titers of EC-V304 were perceptibly reduced to a lower level at 24 h p.i., suggesting that Eps15 is likely to be involved in a stage of viral replication such as RNA or protein production.
Our findings suggest clathrin-dependent pathways play an important role in DV2 entry into endothelial-like ECV304 cells, and the caveolae-dependent pathway is not involved in this process. This is partially consistent with other reports on the Flaviviridae family. Early electron microscopy studies suggested that the flavivirus WNV entered cells through clathrin-coated vesicles (Gollins and Porterfield 1985) . A later study showed that pretreatment of C6/36 cells with pharmacological drugs that block clathrin-mediated endocytosis significantly inhibited virus entry. Furthermore, the transfection of functional blocking antibody against clathrin molecules and the overexpression of dominant-negative mutants of Eps15 in C6/ 36 cells caused a marked reduction in WNV internalization (Chu and Ng 2004) . More recently, several groups have found that entry of WNV, HCV, and DV into mammalian cells was associated with clathrinmediated endocytosis (Blanchard et al. 2006; Krishnan et al. 2007) . It seems that related flaviviruses are likely to utilize similar mechanisms for the entry into host cell.
Previous studies have suggested that the internalization pathways of virus are likely to be cell type dependent. SV40, the first virus shown to enter cells via caveolae, is taken up by clathrin-independent mechanisms in caveolindeficient cells (Damm et al. 2005) . Influenza virus has been described as entering chicken embryo fibroblasts via clathrin-dependent mechanisms (Krizanova et al. 1982) , but it can also enter HeLa cells in the absence of clathrin-mediated endocytosis (Sieczkarski and Whittaker 2002a) . In vivo, the initial target cells for DV infection remain unknown. In vitro, DV infects primary cultures of human liver cells and umbilical endothelial cells, primary human monocytes and dentritic cells, and human epithelial and endothelial cell lines. However, the studies of endocytic mechanisms of DV have focused on human epithelial and endothelial cell lines. In our previous studies, we found that integrin avb3 (Zhang et al. 2007 ) and actin filaments (data to be published) were associated with DV2 entry into human mi- crovascular endothelial cells. Thus, integrin avb3 is likely to be a receptor or coreceptor for DV2 infection, and the initial interaction with DV2 might trigger an internalization signal, which facilitates clathrin-dependent endocytosis of the virus. Further studies are needed to clarify the signal pathways downstream of DV internalization, and the investigations of DV endocytic mechanisms in other cell types are indispensable.
In summary, this report broadens our view of DV2-cell interactions, which might be valuable in the understanding of the entry processes of related flaviviruses and for facilitating the development of novel antiviral therapeutic strategies.
